Literature DB >> 2864065

Celiprolol--pharmacological profile of an unconventional beta-blocker.

P S Wolf, R D Smith, A Khandwala, R G Van Inwegen, R J Gordon, W S Mann, D V Romano, T P Pruss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2864065

Source DB:  PubMed          Journal:  Br J Clin Pract Suppl        ISSN： 0262-8767


× No keyword cloud information.
  5 in total

Review 1.  Efficacy of celiprolol in hypertension and angina pectoris. Introduction.

Authors:  R J Norris
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

2.  Hemodynamic interactions of a new beta blocker, celiprolol, with nifedipine in angina pectoris.

Authors:  B Silke; S P Verma; S Guy
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

3.  Comparative enantioselective pharmacokinetic studies of celiprolol in healthy volunteers and patients with impaired renal function.

Authors:  C Hartmann; M Frölich; D Krauss; H Spahn-Langguth; H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 4.  Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.

Authors:  J G Riddell; R G Shanks; R N Brogden
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

5.  Celiprolol: a positive inotropic beta-adrenoceptor blocking agent in conscious dogs.

Authors:  D M Nganele; V M DeLeonardis; T H Hintze
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.